MAGED2

MAGE Family Member D2 – Key Regulator of Renal Sodium Transport and Water Homeostasis

Gene Information Card

Symbol MAGED2
Full Name MAGE Family Member D2
Gene Type Protein coding
Chromosomal Location Xp11.21
NCBI Gene ID 10916 ncbi.nlm.nih.gov/gene/10916
Ensembl ID ENSG00000102316
UniProt ID Q9UNF1
OMIM ID 300470
HGNC ID 6813
Aliases 11B6, BCG-1, HCA10, MAGE-D2, MGC8386

Description

MAGED2 (MAGE Family Member D2) is a protein-coding gene located on the X chromosome. It belongs to the melanoma-associated antigen (MAGE) family, which is characterized by a conserved MAGE homology domain. The encoded protein is involved in the regulation of renal sodium and water transport, particularly through interaction with the sodium-potassium-chloride cotransporter NKCC2. Loss-of-function mutations in MAGED2 cause Bartter syndrome type 5, a severe antenatal form of salt-losing tubulopathy associated with polyhydramnios and transient renal salt wasting. The gene is widely expressed in adult and fetal tissues, with highest levels in kidney, brain, and testis.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Bartter syndrome type 5 (BARTS5) Loss-of-function mutations in MAGED2 impair NKCC2 trafficking and function, leading to defective renal sodium reabsorption in the thick ascending limb of Henle's loop. OMIM #300971; ClinVar; PMID: 26940518
Transient antenatal Bartter syndrome MAGED2 mutations cause a transient form of Bartter syndrome that resolves postnatally, likely due to developmental regulation of the protein. OMIM #300971; PMID: 26940518
Cancer (potential role) MAGED2 is overexpressed in some cancers (e.g., melanoma, breast cancer) and may contribute to tumor progression through anti-apoptotic mechanisms. COSMIC; PMID: 12527899

Expression Profile

Tissue Expression
Tissue nTPM level
Kidney 15.2 Medium
Brain 10.8 Medium
Testis 20.5 High
Placenta 8.3 Low
Lung 5.1 Low
Cell Line Expression
Cell Line nTPM Notes
HEK 293 12.4 Embryonic kidney cell line
HeLa 7.8 Cervical cancer cell line
MCF7 9.1 Breast cancer cell line
SH-SY5Y 6.5 Neuroblastoma cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.266C>T (p.Pro89Leu) Missense Rare Loss of function; associated with Bartter syndrome type 5
c.1A>G (p.Met1Val) Start loss Rare Loss of function; associated with Bartter syndrome type 5
c.649C>T (p.Arg217*) Nonsense Rare Loss of function; associated with Bartter syndrome type 5
Mutation functional classification

Loss of Function (LOF)

Most reported MAGED2 mutations are loss-of-function, leading to impaired NKCC2 trafficking and Bartter syndrome type 5.

Gain of Function (GOF)

No gain-of-function mutations have been reported in MAGED2.

Dominant Negative (DN)

No dominant-negative mutations have been described for MAGED2.

Pathways

Renal sodium reabsorption (NKCC2 pathway)
MAGE family signaling

Protein Summary

The MAGED2 protein is a 707-amino acid member of the MAGE family, containing a conserved MAGE homology domain. It is localized in the cytoplasm and at the plasma membrane, where it interacts with the sodium-potassium-chloride cotransporter NKCC2 (SLC12A1) to facilitate its proper trafficking and function in the kidney. Loss of MAGED2 leads to defective NKCC2 surface expression, causing severe renal salt wasting. The protein is also implicated in cell differentiation and anti-apoptotic processes, with potential roles in cancer.

Related Products

Product name Cat.No. Species Gene ID
MAGED2 Knockout HEK293 Cell Line EDJ-KQ7211 Human 10916 Details Get a Quote
MAGED2 Knockout HCT 116 Cell Line EDJ-KQ32159 Human 10916 Details Get a Quote
MAGED2 Knockout HeLa Cell Line EDJ-KQ32160 Human 10916 Details Get a Quote
MAGED2 Knockout A-549 Cell Line EDJ-KQ30785 Human 10916 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: